CME Group announced that it will publish its fourth‑quarter and full‑year 2025 earnings on February 4, 2026, with the results posted at 6:00 a.m. Central Time and a conference call scheduled for 7:30 a.m. Central Time.
The announcement follows a record 2024 year in which CME Group generated $6.1 billion in revenue, up 10% year‑over‑year, and $3.7 billion in adjusted net income, with adjusted diluted earnings per share of $10.26. In the fourth quarter of 2024, revenue was $1.5 billion and adjusted diluted EPS was $2.52, setting a high benchmark for the upcoming results.
Investors will be able to review the full financial statements, segment performance, and management commentary on the company’s Investor Relations website once the data is posted. The company will also provide forward guidance for the 2025 fiscal year, giving insight into expected revenue growth, operating margin, and earnings per share.
CME Group’s leadership has highlighted the strong demand across its core derivatives markets—interest rates, equity indexes, foreign exchange, energy, agriculture, and metals—driving the record 2024 performance. The upcoming earnings release will clarify how the firm’s mix of high‑volume, high‑margin products and its investment in technology and market‑making infrastructure translate into 2025 results.
The announcement is a key event for investors and analysts tracking the derivatives market, as the earnings release will provide the first comprehensive view of CME Group’s financial health and strategic priorities for the next fiscal year.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.